A detailed history of Codex Capital Asset Management L.L.C. transactions in Eli Lilly & CO stock. As of the latest transaction made, Codex Capital Asset Management L.L.C. holds 17,000 shares of LLY stock, worth $13.5 Million. This represents 6.68% of its overall portfolio holdings.

Number of Shares
17,000
Previous 18,000 5.56%
Holding current value
$13.5 Million
Previous $15.4 Billion 2.15%
% of portfolio
6.68%
Previous 7.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $772,140 - $960,020
-1,000 Reduced 5.56%
17,000 $15.1 Billion
Q2 2024

Aug 05, 2024

BUY
$724.87 - $909.04 $13 Million - $16.4 Million
18,000 New
18,000 $15.4 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Codex Capital Asset Management L.L.C. Portfolio

Follow Codex Capital Asset Management L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Codex Capital Asset Management L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Codex Capital Asset Management L.L.C. with notifications on news.